The Val158Met COMT polymorphism is a modifier of the age at onset in Parkinson's disease with a sexual dimorphism
نویسندگان
چکیده
The catechol-O-methyltranferase (COMT) is one of the main enzymes that metabolise dopamine in the brain. The Val158Met polymorphism in the COMT gene (rs4680) causes a trimodal distribution of high (Val/Val), intermediate (Val/Met) and low (Met/Met) enzyme activity. We tested whether the Val158Met polymorphism is a modifier of the age at onset (AAO) in Parkinson's disease (PD). The rs4680 was genotyped in a total of 16 609 subjects from five independent cohorts of European and North American origin (5886 patients with PD and 10 723 healthy controls). The multivariate analysis for comparing PD and control groups was based on a stepwise logistic regression, with gender, age and cohort origin included in the initial model. The multivariate analysis of the AAO was a mixed linear model, with COMT genotype and gender considered as fixed effects and cohort and cohort-gender interaction as random effects. COMT genotype was coded as a quantitative variable, assuming a codominant genetic effect. The distribution of the COMT polymorphism was not significantly different in patients and controls (p=0.22). The Val allele had a significant effect on the AAO with a younger AAO in patients with the Val/Val (57.1±13.9, p=0.03) than the Val/Met (57.4±13.9) and the Met/Met genotypes (58.3±13.5). The difference was greater in men (1.9 years between Val/Val and Met/Met, p=0.007) than in women (0.2 years, p=0.81). Thus, the Val158Met COMT polymorphism is not associated with PD in the Caucasian population but acts as a modifier of the AAO in PD with a sexual dimorphism: the Val allele is associated with a younger AAO in men with idiopathic PD.
منابع مشابه
Human Evaluation of the Glu298Asp polymorphism in NOS3 gene and its relationship with onset age of ESRD in Iranian patients suffering from ADPKD
One of the most striking features in autosomal dominant polycystic kidney disease (ADPKD) is the difference at onset age of end-stage renal disease (ESRD). Modifier genes may play a role in this phenotypic variability. The mutated nitric oxide synthase 3 gene (NOS3), have a modifier effect on the severity of ADPKD by impairment of NOS3 activity and decreasing of renal vascular nitric oxide prod...
متن کاملSexual Dimorphism in Surface Anatomical Parameters of Parahippocampal Cortex in Normal Subjects and Those Suffering From Alzheimer and Parkinson's Diseases - a Stereologic and Macroscopic Study
Purpose: This study was designed to determine sex differences in the surface anatomical parameters (surface area and thickness) of the left parahippocampal cortex in healthy right - handed subjects and right - handed subjects suffering from Alzheimer and Parkinson's diseases. Materials and Methods: This cross-sectional descriptive study was performed on 72 normal human brains (38 males, 34 fem...
متن کاملDopaminergic denervation severity depends on COMT Val158Met polymorphism in Parkinson's disease.
BACKGROUND Catecholamine-O-methyl-tranferase (COMT) initiates dopamine degradation. Its activity is mainly determined by a single nucleotide polymorphism in the COMT gene (Val158Met, rs4680) separating high (Val/Val, COMT(HH)), intermediate (Val/Met, COMT(HL)) and low metabolizers (Met/Met, COMT(LL)). We investigated dopaminergic denervation in the striatum in PD patients according to COMT rs46...
متن کاملSexual Dimorphism in Surface Anatomical Parameters of Human Cerebral Cortex in Different Lebes in Normal and Neurodegenerative Subjects: a Stereological and Macroscopical Study
Purpose: This study sought to determine sex differences in surface anatomical parameters (thickness and surface areas) of human cerebral cortex in different lobes of the left hemisphere in normal right-handed subjects and right-handed subjects suffering from Alzheimer and Parkinson's diseases. Materials and Methods: This cross-sectional descriptive study was performed on 72 normal human brains...
متن کاملThe val158met COMT polymorphism's effect on atrophy in healthy aging and Parkinson's disease
We investigated whether the val(158)met functional polymorphism of catechol-o-methyltransferase influenced age-related changes in grey matter density and volume, both in healthy individuals (n=80, ages 18-79) and those with Parkinson's disease (n=50). Global grey matter volumes and voxelwise estimates of grey matter volume and density were determined from structural magnetic resonance images at...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره 84 شماره
صفحات -
تاریخ انتشار 2013